BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18536030)

  • 1. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
    Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.
    Lee CC; Ho HC; Lee MS; Hung SK; Yu CC; Su YC
    Clin Chim Acta; 2010 Aug; 411(15-16):1116-21. PubMed ID: 20417195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age.
    Pytynia KB; Grant JR; Etzel CJ; Roberts D; Wei Q; Sturgis EM
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):869-73. PubMed ID: 15262765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
    Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
    Scand J Immunol; 2008 Apr; 67(4):392-9. PubMed ID: 18282234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.
    Gillespie MB; Moody MW; Lee FS; Poole LJ; Hornig JD; Lathers D; Young MR; Day TA
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):28-31. PubMed ID: 17224518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Olofsson J
    Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
    Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
    Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma.
    Brandwein-Gensler M; Smith RV; Wang B; Penner C; Theilken A; Broughel D; Schiff B; Owen RP; Smith J; Sarta C; Hebert T; Nason R; Ramer M; DeLacure M; Hirsch D; Myssiorek D; Heller K; Prystowsky M; Schlecht NF; Negassa A
    Am J Surg Pathol; 2010 May; 34(5):676-88. PubMed ID: 20414102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
    Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
    Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
    Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study.
    De Boer MF; Van den Borne B; Pruyn JF; Ryckman RM; Volovics L; Knegt PP; Meeuwis CA; Mesters I; Verwoerd CD
    Cancer; 1998 Dec; 83(12):2567-79. PubMed ID: 9874465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.